皮膚線維症治療市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPRE00016848
  • Category : Pharmaceuticals
  • Status : Upcoming
  • No. of Pages : 150
Buy Now

市場紹介

皮膚線維症は、皮膚の下にコラーゲンやその他の細胞外マトリックス (ECM) 分子が持続的に蓄積することを特徴としています。皮膚線維症は、肥厚性瘢痕、強皮症、ケロイドなどのさまざまな皮膚疾患の不可欠な部分です。これらの疾患は、真皮線維芽細胞の活性化を通じて結合組織代謝の調節不全を引き起こします。コルチコステロイド、免疫療法薬、免疫グロブリン、および抗線維化薬は、皮膚線維症および関連する皮膚疾患の治療に一般的に使用されます。

MARKD TYNAMICS

皮膚線維症治療市場は、予測期間中に大きな発展を示しました。主な要因としては、強皮症、移植片対宿主病(GVHD)、ケロイド(重症型)などの皮膚線維症関連疾患の発生率の増加が挙げられます。強皮症および皮膚線維症に関連するその他の疾患は、35 ~ 40 歳以上の人に多く見られます。世界中、特に先進地域における人口の高齢化により、皮膚線維症に関連する適応症の有病率が増加し、したがって皮膚線維症の有病率が増加すると予想されます。発展途上国では先進国よりも急速に高齢化が進んでいます。例えば、フランスでは高齢化社会への転換に115年以上を要したが、中国では同様の転換に25年しか要さなかったと推定されている。さらに、数多くの手術、交通事故、外傷により、身体的外傷に関連したケロイド瘢痕の有病率も増加すると予想されます。しかし、皮膚線維症は一般に、ケロイド、GVHD、強皮症、または放射線療法などの疾患に苦しむ人々に影響を与えます。皮膚線維症はまれな病気です。医療従事者と一般住民の間の認識が限られているため、皮膚線維症の診断と治療が遅れ、それによって市場の成長が妨げられます。

市場範囲

「2028 年までの皮膚線維症治療市場分析」は、世界市場動向分析に焦点を当てた、ヘルスケア業界の医薬品に関する専門的で詳細な調査です。このレポートは、疾患の適応症、投与経路、エンドユーザーごとの詳細な市場分割とともに、皮膚線維症治療市場の概要を提供します。皮膚線維症治療市場は、予測期間中に急激に上昇すると予想されます。このレポートは、皮膚線維症治療市場の主要企業の市場状況に関する主要な統計に焦点を当てており、主要な傾向と機会を提供します。

市場の分割

市場は適応症、投与経路、エンドユーザーに従って分割されます。適応症に基づいて、市場はケロイド、強皮症、放射線誘発性皮膚線維症、GVHD関連皮膚線維症に分類されます。投与経路に基づいて、市場は経口、注射、局所に分類されます。エンドユーザーに基づいて、市場は病院、診療所などに分類されます。

地域の枠組み

このレポートは、定量的および定性的な情報を含む業界の包括的な概要を提供します。このレポートは、さまざまなセグメントに基づいて皮膚線維症治療市場の概要と予測を提供します。また、北米、ヨーロッパ、アジア太平洋 (APAC)、中東およびアフリカ (MEA)、中南米の 5 つの主要地域の 2020 年から 2028 年の市場規模と予測推定も提供します。その後、各地域の市場はそれぞれの国とセグメントに分割されます。このレポートは、世界 18 か国の分析と予測、ならびにこの地域の最近の傾向と機会をカバーしています。レポートは、需要と供給の両方の側面から皮膚線維症治療市場に影響を与える要因を分析します。さらに、予測期間中に市場に影響を与える市場ダイナミクス、つまり推進要因、制約、機会、将来の傾向を評価します。このレポートには、5 つの地域すべてに対する詳細な PEST 分析も含まれています。北米、ヨーロッパ、APAC、MEA、中南米、これらの地域の皮膚線維症治療市場に影響を与える政治的、経済的、社会的、技術的要因を評価した後。

市場関係者

このレポートには、皮膚線維症治療市場の主要な動向と有機的および無機的な成長戦略が含まれています。さまざまな企業が、製品の発売、製品の承認、特許やイベントなどの有機的な成長戦略に焦点を当てています。市場で観察された無機的な成長戦略には、買収だけでなくパートナーシップやコラボレーションも含まれていました。これらの活動により、市場参加者のビジネスと顧客ベースの拡大への道が開かれました。皮膚線維症治療市場の需要が世界的に増加しているため、皮膚線維症治療市場の市場関係者は、今後数年間で収益性の高い成長機会を目撃すると予想されています。以下は、皮膚線維症の治療市場で活動している企業のリストです。レポートには、SWOT分析と市場戦略とともに、皮膚線維症治療市場の主要プレーヤーのプロフィールも含まれています。さらに、このレポートでは、企業概要、提供されるコンポーネントとサービス、過去 3 年間の財務情報、および過去 5 年間の主要な開発に関する情報とともに、業界の主要企業について説明しています。
    • Gilead Sciences, Inc. • Novartis AG • F. Hoffmann-La Roche Ltd • Teva Pharmaceutical Industries Ltd • AstraZeneca • Bayer AG • Bristol-Myers Squibb • Sanofi • Genentech • BoehringerIngelheim International GmbH
Insight パートナーは次のとおりです。専任の調査分析チームは、高度な統計専門知識を持つ経験豊富な専門家で構成されており、現在の調査においてさまざまなカスタマイズ オプションを提供しています。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The List of Companies

1. Gilead Sciences, Inc.
2. Novartis AG
3. F. Hoffmann-La Roche Ltd
4. Teva Pharmaceutical Industries Ltd
5. AstraZeneca
6. Bayer AG
7. Bristol-Myers Squibb
8. Sanofi
9. GlaxoSmithKline plc.
10. Boehringer Ingelheim International GmbH

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports